REALITY

”Treatment is not yet necessary”: delays in seeking access to HIV treatment in Uganda and Zimbabwe

26 Dec, 2018

Authors: Kawuma R, Seeley J, Mupambireyi Z, Cowan F, Bernays S; for REALITY Trial Team Published in: Afr J AIDS Res. 2018;17(3):217-225 Abstract We examined the logic that individuals use to account for delaying HIV testing…
Read More

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial

26 Mar, 2018

Authors: Mallewa J, Szubert AJ, Mugyenyi P, et al. Published in: Lancet HIV. 2018;5(5):e231-e240 Background In sub-Saharan Africa, severely immunocompromised HIV-infected individuals have a high risk of mortality during the first few…
Read More

Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: a randomised controlled trial

26 Mar, 2018

Authors: Kityo C, Szubert AJ, Siika A, et al. Published in: PLoS Med. 2018; 15(12):e1002706 Background In sub-Saharan Africa, individuals infected with HIV who are severely immunocompromised have high mortality (about 10%)…
Read More

Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial

26 Mar, 2018

Authors: Post FA, Szubert AJ, Prendergast AJ, et al; for Reduction of early mortality in HIV-infected adults and children starting an antiretroviral therapy (REALITY) trial team Published in: Clin Infect Dis. 2018;66(2):S132-S139 Background In sub-Saharan…
Read More

Late presentation with HIV in Africa: phenotypes, risk, and risk stratification in the REALITY Trial

26 Mar, 2018

Authors: Siika A, McCabe L, Bwakura-Dangarembizi M, et al; for REALITY Trial Team Published in: Clin Infect Dis. 2018;66(2):S140-S146 Background Severely immunocompromised human immunodeficiency virus (HIV)–infected individuals have high mortality shortly after starting antiretroviral therapy…
Read More

Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa

10 Dec, 2017

Authors: Hakim J, Musiime V, Szubert AJ; REALITY Trial Team Published in: N Engl J Med. 2017;377(3):233-245 Background In sub-Saharan Africa, among patients with advanced human immunodeficiency virus (HIV) infection, the rate…
Read More